AstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancer

(RTTNews) - Drug major, AstraZeneca Plc (AZN.L, AZN) said on Monday that its Tagrisso, a brand name of Osimertinib used to treat non-small-cell lung carcinomas with specific mutations, has been approved with the addition of chemotherapy. https://www.nasdaq.com/articles/astrazenecas-tagrisso-with-chemotherapy-approved-in-us-to-treat-lung-cancer